FDA Clearance Tracker · P150011-S013
Perceval Sutureless Heart Valve
Last checked: Nov 20, 2026Latest source record: Oct 16, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Oct 16, 2020
Approved
Time to decision
899 days
Received May 1, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P150011-S013
- Device name
- Perceval Sutureless Heart Valve
- Applicant
- Corcym S.r.l.
- Applicant location
- Saluggia
- Received
- May 1, 2018
- Decided
- Oct 16, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P150011
Device type
- Device type
- heart-valve, non-allograft tissue (LWR)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for a new Perceval device model, the Perceval PLUS Sutureless Heart Valve, including a modification to the bovine pericardial tissue chemical treatment process and a reduction of the inflow ring height for the size XL valve.
Source documents
Other decisions for Corcym S.r.l.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261707 · Decided Jun 18, 2026 · 27 days after receipt
Device type: Ring, Annuloplasty (KRH) · Cardiology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.